The UK approves Pfizer’s antiviral Covid-19 pill
Based on data, the pill, Paxlovid, is most effective when taken in the early stages of Covid-19
The UK has approved Pfizer’s Covid-19 pill for patients over the age of 18 who have mild to moderate infection and are at high risk for their disease to worsen.
The approval comes as the country struggles to build its defense amid a record-breaking daily record of new Covid-19 cases on Thursday, government data showed an increase in Covid-19 cases.
Based on data, the pill, Paxlovid, is most effective when taken in the early stages of Covid-19, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) said on Friday, recommending that the drug be used within five days of starting. symptoms.
Pfizer said this month that Paxlovid showed nearly 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent laboratory data suggest the drug retains its effectiveness against the rapidly spreading Omicron variant of coronavirus.
“We now have an additional antiviral drug to treat Covid-19 that can be taken by mouth instead of being administered intravenously. That means it can be administered outside of a hospital setting,” MHRA chief June Raine said in a statement.
Watch the latest DH videos here: